Diuresis via kidney tubule modulation

Diuresis via kidney tubule modulation is a physiological process and pharmacological mechanism characterized by the increased excretion of water and electrolytes through the modification of transport proteins within the nephron (StatPearls, 2023). This process involves several distinct molecular targets located along the renal tubule, including the sodium-potassium-chloride cotransporter (NKCC2) in the thick ascending limb of the Loop of Henle and the sodium-chloride symporter (NCC) in the distal convoluted tubule (NCBI, 2023). Additionally, it encompasses the modulation of the epithelial sodium channel (ENaC) in the collecting duct and the sodium-glucose cotransporter 2 (SGLT2) in the proximal tubule (PubMed, 2022). By inhibiting these transporters, diuretic drugs decrease the reabsorption of sodium and other solutes, which reduces the osmotic gradient required for water reabsorption, thereby increasing urine volume (Wikipedia, 2024). This mechanism is therapeutically essential for managing volume-overload states such as congestive heart failure, pulmonary edema, and liver cirrhosis (NIH, 2023). It also plays a critical role in the management of hypertension by reducing extracellular fluid volume and peripheral vascular resistance (StatPearls, 2023). However, modulating these pathways carries significant risks of electrolyte disturbances, including hypokalemia, hyponatremia, and hypomagnesemia, which require careful clinical monitoring (NCBI, 2023). Therapeutic challenges also include the development of diuretic resistance and the potential for acute kidney injury due to excessive volume depletion (PubMed, 2021).

Other names

Renal tubular diuresisDiuretic effectModulation of renal solute transportKidney tubule ion transport modulation

Inhibition of renal tubular transport proteins and enzymes to decrease solute and water reabsorption, thereby increasing urinary excretion.